Olaparib for childhood tumors harboring defects in DNA damage repair genes: arm H of the NCI-COG Pediatric MATCH trial.
Julia L Glade BenderKerice PinkneyPaul M WilliamsSinchita Roy-ChowdhuriDavid R PattonBrent D CoffeyJoel M ReidJin PiaoLauren SaguiligTodd A AlonzoStacey L BergNilsa C RamirezElizabeth FoxBrenda J WeigelDouglas S HawkinsMargaret M MooneyNaoko TakebeJames V TricoliKatherine A JanewayNita L SeibelDonald W ParsonsPublished in: The oncologist (2024)
NCT03233204. IRB approved: initial July 24, 2017.